Advisors Asset Management, Inc.
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1297376
Monument, CO
Position in PTGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$489,477
+$78,630 QoQ
Shares Held
4,644
-1.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $39,929,265 across 31 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,909 | $12,869,777 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
17,228 | $5,445,598 | |
| 3 | INCY |
Incyte Corp
|
24,359 | $2,761,336 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
95,934 | $2,515,389 | |
| 5 | ASND |
Ascendis Pharma A/S
|
9,146 | $2,439,421 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
21,896 | $2,431,112 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,379 | $1,483,401 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
15,280 | $1,246,389 |
All Filings in PTGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $489,477 | 4,644 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $410,847 | 4,704 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $312,619 | 4,706 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $261,095 | 4,724 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $228,307 | 4,721 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $100,282 | 2,598 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||